Shanglei Ning

1.6k total citations · 1 hit paper
28 papers, 1.2k citations indexed

About

Shanglei Ning is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Shanglei Ning has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 14 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Shanglei Ning's work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Cancer-related molecular mechanisms research (4 papers) and Pancreatic function and diabetes (4 papers). Shanglei Ning is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Cancer-related molecular mechanisms research (4 papers) and Pancreatic function and diabetes (4 papers). Shanglei Ning collaborates with scholars based in China, United States and Portugal. Shanglei Ning's co-authors include Yunfei Xu, Yuxiong Feng, Yun Zhang, Dong Xie, Geoffrey J. Markowitz, Shan Jiang, Yuezhen Deng, Yunfei Yuan, Pengyuan Yang and Qi-Jing Li and has published in prestigious journals such as Cancer Cell, Cell Metabolism and Oncogene.

In The Last Decade

Shanglei Ning

27 papers receiving 1.2k citations

Hit Papers

TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitme... 2012 2026 2016 2021 2012 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shanglei Ning China 16 695 400 329 223 186 28 1.2k
Mitsukazu Gotoh Japan 18 365 0.5× 275 0.7× 300 0.9× 187 0.8× 150 0.8× 30 820
Hsei-Wei Wang Taiwan 22 1.3k 1.8× 548 1.4× 531 1.6× 294 1.3× 121 0.7× 29 1.9k
Shu Shimada Japan 22 1.0k 1.5× 604 1.5× 354 1.1× 124 0.6× 89 0.5× 43 1.4k
Massimo Pancione Italy 21 659 0.9× 370 0.9× 427 1.3× 88 0.4× 165 0.9× 48 1.2k
Lucia Fallavollita Canada 17 669 1.0× 421 1.1× 685 2.1× 109 0.5× 292 1.6× 23 1.5k
Yuquan Xiong United States 16 1.1k 1.5× 442 1.1× 520 1.6× 153 0.7× 657 3.5× 20 1.9k
Yan‐Miao Huo China 21 559 0.8× 435 1.1× 534 1.6× 150 0.7× 276 1.5× 54 1.2k
Baochi Ou China 17 602 0.9× 302 0.8× 403 1.2× 71 0.3× 224 1.2× 26 1.1k
Zongliu Hou China 19 445 0.6× 194 0.5× 284 0.9× 167 0.7× 184 1.0× 59 993
Juling Ji China 14 646 0.9× 384 1.0× 225 0.7× 92 0.4× 334 1.8× 36 1.3k

Countries citing papers authored by Shanglei Ning

Since Specialization
Citations

This map shows the geographic impact of Shanglei Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanglei Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanglei Ning more than expected).

Fields of papers citing papers by Shanglei Ning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanglei Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanglei Ning. The network helps show where Shanglei Ning may publish in the future.

Co-authorship network of co-authors of Shanglei Ning

This figure shows the co-authorship network connecting the top 25 collaborators of Shanglei Ning. A scholar is included among the top collaborators of Shanglei Ning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanglei Ning. Shanglei Ning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Kaiyu, Haibo Qi, Wentao An, et al.. (2024). Differential contributions of G protein‐ or arrestin subtype‐mediated signalling underlie urocortin 3‐induced somatostatin secretion in pancreatic δ cells. British Journal of Pharmacology. 181(15). 2600–2621. 1 indexed citations
2.
Cheng, Qian, et al.. (2023). NDRG1 facilitates self-renewal of liver cancer stem cells by preventing EpCAM ubiquitination. British Journal of Cancer. 129(2). 237–248. 10 indexed citations
3.
Li, Hailin, et al.. (2023). In situ subtotal spleen resection combined with selective pericardial devascularization for the treatment of portal hypertension. World Journal of Gastrointestinal Surgery. 15(4). 634–642.
4.
Cheng, Jie, Zhao Yang, Xin Xu, et al.. (2022). Autonomous sensing of the insulin peptide by an olfactory G protein-coupled receptor modulates glucose metabolism. Cell Metabolism. 34(2). 240–255.e10. 39 indexed citations
5.
Ning, Shanglei, et al.. (2021). Case Report: Incidentally Discovered a Rare Cystic Lesion of Liver: Multicystic Biliary Hamartoma. Pathology & Oncology Research. 27. 628323–628323. 5 indexed citations
6.
Guo, Lingyu, et al.. (2021). Long Noncoding RNA SNHG1 Regulates LMNB2 Expression by Sponging miR-326 and Promotes Cancer Growth in Hepatocellular Carcinoma. Frontiers in Oncology. 11. 784067–784067. 9 indexed citations
7.
Xu, Yunfei, Zengli Liu, Chang Pan, et al.. (2018). HMGB1 correlates with angiogenesis and poor prognosis of perihilar cholangiocarcinoma via elevating VEGFR2 of vessel endothelium. Oncogene. 38(6). 868–880. 64 indexed citations
8.
Li, Na, Zhao Yang, Qing Li, et al.. (2018). Ablation of somatostatin cells leads to impaired pancreatic islet function and neonatal death in rodents. Cell Death and Disease. 9(6). 682–682. 29 indexed citations
9.
Li, Hui, Shanglei Ning, Yinghui Xu, et al.. (2017). Switching of the substrate specificity of protein tyrosine phosphatase N12 by cyclin‐dependent kinase 2 phosphorylation orchestrating 2 oncogenic pathways. The FASEB Journal. 32(1). 73–82. 10 indexed citations
11.
Liu, Hongda, Yunfei Xu, Qun Zhang, et al.. (2017). Correlations between TBL1XR1 and recurrence of colorectal cancer. Scientific Reports. 7(1). 44275–44275. 56 indexed citations
12.
Yang, Hongling, et al.. (2016). Clinical Outcomes of Patients with Severe Hepatic Hereditary Hemorrhagic Telangiectasia After Banding of the Hepatic Artery and Banding/Ligation of Branches of the Hepatic Artery. European Journal of Vascular and Endovascular Surgery. 51(4). 594–601. 10 indexed citations
13.
Liu, Hongda, Yunfei Xu, Qun Zhang, et al.. (2016). Prognostic significance of TBL1XR1 in predicting liver metastasis for early stage colorectal cancer. Surgical Oncology. 26(1). 13–20. 75 indexed citations
14.
Wang, Hongmei, Yunfei Xu, Shanglei Ning, et al.. (2014). The catalytic region and PEST domain of PTPN18 distinctly regulate the HER2 phosphorylation and ubiquitination barcodes. Cell Research. 24(9). 1067–1090. 67 indexed citations
15.
Xu, Yunfei, Xiaoqing Yang, Xiaofei Lü, et al.. (2014). Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma. Biochemical and Biophysical Research Communications. 446(1). 54–60. 80 indexed citations
16.
Ning, Shanglei, et al.. (2013). TROP2 expression and its correlation with tumor proliferation and angiogenesis in human gliomas. Neurological Sciences. 34(10). 1745–1750. 29 indexed citations
17.
Yang, Pengyuan, Qi-Jing Li, Yuxiong Feng, et al.. (2012). TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma. Cancer Cell. 22(3). 291–303. 456 indexed citations breakdown →
18.
Ning, Shanglei, Sen Guo, Jian‐Jun Xie, et al.. (2012). TROP2 Correlates with Microvessel Density and Poor Prognosis in Hilar Cholangiocarcinoma. Journal of Gastrointestinal Surgery. 17(2). 360–368. 33 indexed citations
19.
Chen, Hongqiang, et al.. (2011). Budd–Chiari Syndrome Caused by Multiple Membranous Obstruction of the Inferior Vena Cava in a Young Man. Annals of Vascular Surgery. 25(8). 1139.e5–1139.e7. 1 indexed citations
20.
Ning, Shanglei, et al.. (2010). Malignant solitary fibrous tumor of the thyroid gland: Report of a case and review of the literature. Diagnostic Cytopathology. 39(9). 694–699. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026